Ascentage Pharma Group International
Key Figures
17.600Open
17.600High
4.00KVolume
--P/E TTM
LossP/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
18.070Prev. Close
17.240Low
49.94KTurnover
--P/E Static
33.89P/B
0.00%Div Yield TTM
--ROA
48.45052wk High
1.14Volume Ratio
--Net Profit
373.32MShares
--EPS TTM
--Beta
--ROE
18.56052wk Low
1.99%Amplitude
--Gross Margin
1.61BMarket Cap
-2.98Reward/Risk
2.25%Risk Rate
Ascentage Pharma Group International News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ascentage Pharma Group International
AAPG
9
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Ascentage Pharma Group International Info
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.
Ticker SymbolAAPG
CompanyAscentage Pharma Group International
CEOYang (Dajun)
Websitehttps://www.ascentage.cn/
Shareholders
FAQs
What is the current price of Ascentage Pharma Group International (AAPG)?
The current price of Ascentage Pharma Group International (AAPG) is 17.43.
What is the symbol of Ascentage Pharma Group International?
The ticker symbol of Ascentage Pharma Group International is AAPG.
What is the 52-week high of Ascentage Pharma Group International?
The 52-week high of Ascentage Pharma Group International is 48.45.
What is the 52-week low of Ascentage Pharma Group International?
The 52-week low of Ascentage Pharma Group International is 18.56.
What is the market capitalization of Ascentage Pharma Group International?
The market capitalization of Ascentage Pharma Group International is 1.61B.
Is Ascentage Pharma Group International (AAPG) currently rated as Buy, Hold, or Sell?
According to analysts, Ascentage Pharma Group International (AAPG) has an overall rating of Buy, with a price target of 47.75.
What is the Earnings Per Share (EPS TTM) of Ascentage Pharma Group International (AAPG)?
The Earnings Per Share (EPS TTM) of Ascentage Pharma Group International (AAPG) is -2.00.
